Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection

View ORCID ProfileFeargal J. Ryan, View ORCID ProfileChristopher M. Hope, View ORCID ProfileMakutiro G. Masavuli, View ORCID ProfileMiriam A. Lynn, View ORCID ProfileZelalem A. Mekonnen, Arthur Eng Lip Yeow, View ORCID ProfilePablo Garcia-Valtanen, Zahraa Al-Delfi, Jason Gummow, Catherine Ferguson, Stephanie O’Connor, Benjamin AJ Reddi, David Shaw, Chuan Kok-Lim, View ORCID ProfileJonathan M. Gleadle, View ORCID ProfileMichael R. Beard, View ORCID ProfileSimon C. Barry, View ORCID ProfileBranka Grubor-Bauk, David J. Lynn
doi: https://doi.org/10.1101/2021.07.30.21261234
Feargal J. Ryan
1Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA 5001, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Feargal J. Ryan
Christopher M. Hope
2Women’s and Children’s Health Network, North Adelaide, SA, Australia
3Molecular Immunology, Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christopher M. Hope
Makutiro G. Masavuli
4Viral Immunology Group, Adelaide Medical School, University of Adelaide and Basil Hetzel Institute for Translational Health Research, Adelaide, SA, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Makutiro G. Masavuli
Miriam A. Lynn
1Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA 5001, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Miriam A. Lynn
Zelalem A. Mekonnen
4Viral Immunology Group, Adelaide Medical School, University of Adelaide and Basil Hetzel Institute for Translational Health Research, Adelaide, SA, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Zelalem A. Mekonnen
Arthur Eng Lip Yeow
4Viral Immunology Group, Adelaide Medical School, University of Adelaide and Basil Hetzel Institute for Translational Health Research, Adelaide, SA, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pablo Garcia-Valtanen
4Viral Immunology Group, Adelaide Medical School, University of Adelaide and Basil Hetzel Institute for Translational Health Research, Adelaide, SA, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pablo Garcia-Valtanen
Zahraa Al-Delfi
4Viral Immunology Group, Adelaide Medical School, University of Adelaide and Basil Hetzel Institute for Translational Health Research, Adelaide, SA, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jason Gummow
5Gene Silencing and Expression Core Facility, Adelaide Health and Medical Sciences, Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine Ferguson
6Infectious Diseases Department, Royal Adelaide Hospital, Central Adelaide Local Health Network, Adelaide, SA, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephanie O’Connor
7Intensive Care Unit, Royal Adelaide Hospital, Central Adelaide Local Health Network and Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin AJ Reddi
7Intensive Care Unit, Royal Adelaide Hospital, Central Adelaide Local Health Network and Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Shaw
6Infectious Diseases Department, Royal Adelaide Hospital, Central Adelaide Local Health Network, Adelaide, SA, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chuan Kok-Lim
6Infectious Diseases Department, Royal Adelaide Hospital, Central Adelaide Local Health Network, Adelaide, SA, Australia
8Microbiology and Infectious Diseases Department, SA Pathology, Adelaide, SA, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan M. Gleadle
9Department of Renal Medicine, Flinders Medical Centre, Flinders University, Bedford Park, SA, 5042, Australia
10Flinders Health and Medical Research Institute, Flinders University, Bedford Park, SA 5042, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jonathan M. Gleadle
Michael R. Beard
11Research Centre for Infectious Diseases, School of Biological Sciences, University of Adelaide, Adelaide, SA 5005, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael R. Beard
Simon C. Barry
2Women’s and Children’s Health Network, North Adelaide, SA, Australia
3Molecular Immunology, Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Simon C. Barry
  • For correspondence: david.lynn@sahmri.com branka.grubor@adelaide.edu.au simon.barry@adelaide.edu.au
Branka Grubor-Bauk
4Viral Immunology Group, Adelaide Medical School, University of Adelaide and Basil Hetzel Institute for Translational Health Research, Adelaide, SA, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Branka Grubor-Bauk
  • For correspondence: david.lynn@sahmri.com branka.grubor@adelaide.edu.au simon.barry@adelaide.edu.au
David J. Lynn
1Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA 5001, Australia
10Flinders Health and Medical Research Institute, Flinders University, Bedford Park, SA 5042, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: david.lynn@sahmri.com branka.grubor@adelaide.edu.au simon.barry@adelaide.edu.au
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Increasing evidence suggests immune dysregulation in individuals recovering from SARS- CoV-2 infection. We have undertaken an integrated analysis of immune responses at a transcriptional, cellular, and serological level at 12, 16, and 24 weeks post-infection (wpi) in 69 individuals recovering from mild, moderate, severe, or critical COVID-19. Anti-Spike and anti-RBD IgG responses were largely stable up to 24wpi and correlated with disease severity. Deep immunophenotyping revealed significant differences in multiple innate (NK cells, LD neutrophils, CXCR3+ monocytes) and adaptive immune populations (T helper, T follicular helper and regulatory T cells) in COVID-19 convalescents compared to healthy controls, which were most strongly evident at 12 and 16wpi. RNA sequencing suggested ongoing immune and metabolic dysregulation in convalescents months after infection. Variation in the rate of recovery from infection at a cellular and transcriptional level may explain the persistence of symptoms associated with long COVID in some individuals.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was financially supported by grants from The Hospital Research Foundation, Flinders Foundation, The Womens and Childrens Hospital Foundation, and the Flinders University College of Medicine and Public Health COVID-19 grant scheme.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Study participants were recruited via the Central Adelaide Health Network (CALHN). The study was performed in accordance with the ethical principles consistent with the latest version of the Declaration of Helsinki (version Fortaleza 2013), Good Clinical Practice (GCP) and according to the National Health and Medical Research Council (NHMRC) Guidelines for Research published in the National Statement on the Ethical Conduct in Human Research (2007; updated 2018). The protocol was approved CALHN Human Research Ethics Committee, Adelaide, Australia (Approval No. 13050)

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

RNA-Seq data have been deposited in the Gene Expression Omnibus (GEO) under accession GSE169687. Count tables, metadata, and R code for all analyses (serology, flow cytometry and RNA-Seq) have been uploaded to the Lynn Laboratory BitBucket (https://bitbucket.org/lynnlab/covid-sa).

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted August 03, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection
Feargal J. Ryan, Christopher M. Hope, Makutiro G. Masavuli, Miriam A. Lynn, Zelalem A. Mekonnen, Arthur Eng Lip Yeow, Pablo Garcia-Valtanen, Zahraa Al-Delfi, Jason Gummow, Catherine Ferguson, Stephanie O’Connor, Benjamin AJ Reddi, David Shaw, Chuan Kok-Lim, Jonathan M. Gleadle, Michael R. Beard, Simon C. Barry, Branka Grubor-Bauk, David J. Lynn
medRxiv 2021.07.30.21261234; doi: https://doi.org/10.1101/2021.07.30.21261234
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection
Feargal J. Ryan, Christopher M. Hope, Makutiro G. Masavuli, Miriam A. Lynn, Zelalem A. Mekonnen, Arthur Eng Lip Yeow, Pablo Garcia-Valtanen, Zahraa Al-Delfi, Jason Gummow, Catherine Ferguson, Stephanie O’Connor, Benjamin AJ Reddi, David Shaw, Chuan Kok-Lim, Jonathan M. Gleadle, Michael R. Beard, Simon C. Barry, Branka Grubor-Bauk, David J. Lynn
medRxiv 2021.07.30.21261234; doi: https://doi.org/10.1101/2021.07.30.21261234

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetic and Genomic Medicine
Subject Areas
All Articles
  • Addiction Medicine (271)
  • Allergy and Immunology (559)
  • Anesthesia (135)
  • Cardiovascular Medicine (1778)
  • Dentistry and Oral Medicine (240)
  • Dermatology (173)
  • Emergency Medicine (317)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (662)
  • Epidemiology (10834)
  • Forensic Medicine (8)
  • Gastroenterology (595)
  • Genetic and Genomic Medicine (2968)
  • Geriatric Medicine (289)
  • Health Economics (534)
  • Health Informatics (1938)
  • Health Policy (837)
  • Health Systems and Quality Improvement (747)
  • Hematology (295)
  • HIV/AIDS (634)
  • Infectious Diseases (except HIV/AIDS) (12535)
  • Intensive Care and Critical Care Medicine (697)
  • Medical Education (300)
  • Medical Ethics (89)
  • Nephrology (325)
  • Neurology (2819)
  • Nursing (152)
  • Nutrition (435)
  • Obstetrics and Gynecology (560)
  • Occupational and Environmental Health (600)
  • Oncology (1475)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (259)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (382)
  • Pediatrics (870)
  • Pharmacology and Therapeutics (368)
  • Primary Care Research (341)
  • Psychiatry and Clinical Psychology (2653)
  • Public and Global Health (5393)
  • Radiology and Imaging (1019)
  • Rehabilitation Medicine and Physical Therapy (599)
  • Respiratory Medicine (729)
  • Rheumatology (330)
  • Sexual and Reproductive Health (294)
  • Sports Medicine (280)
  • Surgery (329)
  • Toxicology (48)
  • Transplantation (151)
  • Urology (127)